What Research Reveals About Safety The preclinical safety data for BPC-157 is more thorough than for most peptides in this category, though the human evidence base remains thin
Like anybody who's ever taken modafinil, especially if you've taken like a moderately high dose, you know, after a couple of months of using all of sudden, one afternoon, you're just sitting there and it's like somebody's hitting your head with a sledgehammer and you're like, I don't think I should be taking this
In the GLP-1 RA vs DPP-4 inhibitor cohort, GLP-1 RA use was associated with lower risk among patients with recent psychiatric history, and no difference among patient without recent psychiatric history
And if detox is your middle name, our glutathione detox ideas have got you covered
B12 Injections
[18] Glatter & Shah, Does Direct-to-Consumer Advertising Directly Harm Patients